Literature DB >> 9444569

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.

F J Jiménez-Jiménez1, F de Bustos, J A Molina, J Benito-León, A Tallón-Barranco, T Gasalla, M Ortí-Pareja, F Guillamón, J C Rubio, J Arenas, R Enríquez-de-Salamanca.   

Abstract

We compared CSF and serum levels, and the CST/serum ratio of alpha-tocopherol (vitamin E), measured by HPLC, in 44 apparently well-nourished patients with Alzheimer's disease (AD) and 37 matched controls. CSF and serum vitamin E levels were correlated, both in AD patients and in controls. The mean CSF and serum vitamin E levels were significantly lower in AD patients, and the CSF/serum ratio of AD patients did not differ significantly between the 2 study groups. CSF vitamin E levels did not correlate with age, age at onset, duration of the disease and score of the Minimental State Examination in the AD group. Weight and body mass index were significantly lower in AD patients than in controls. These results suggest that low CSF and serum vitamin E concentrations in AD patients could be related with a deficiency of dietary intake of vitamin E.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444569     DOI: 10.1007/BF01291887

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

1.  Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

Authors:  P Férnandez-Calle; J A Molina; F J Jiménez-Jiménez; A Vázquez; M Pondal; P J García-Ruiz; D G Urra; J Domingo; R Codoceo
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

2.  Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings.

Authors:  R Sulkava; M Haltia; A Paetau; J Wikström; J Palo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

3.  Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease.

Authors:  J A Molina; F de Bustos; F J Jiménez-Jiménez; J Benito-León; T Gasalla; M Ortí-Pareja; L Vela; F Bermejo; M A Martín; Y Campos; J Arenas
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

4.  Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.

Authors:  T Metcalfe; D M Bowen; D P Muller
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

5.  Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro.

Authors:  K V Subbarao; J S Richardson; L C Ang
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

6.  Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

Authors:  J D Adams; L K Klaidman; I N Odunze; H C Shen; C A Miller
Journal:  Mol Chem Neuropathol       Date:  1991-06

7.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Authors:  P Mecocci; U MacGarvey; M F Beal
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

8.  No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.

Authors:  J E Ahlskog; R J Uitti; P A Low; G M Tyce; K K Nickander; R C Petersen; E Kokmen
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

9.  Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.

Authors:  C M Morris; J M Kerwin; J A Edwardson
Journal:  Neurodegeneration       Date:  1994-12

10.  Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease.

Authors:  A M Palmer; M A Burns
Journal:  Brain Res       Date:  1994-05-09       Impact factor: 3.252

View more
  24 in total

Review 1.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

Review 3.  Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Authors:  Nicolas Farina; David Llewellyn; Mokhtar Gad El Kareem Nasr Isaac; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2017-01-27

4.  Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance.

Authors:  Kenneth Hensley; Lisa L Barnes; Alexandar Christov; Christy Tangney; William G Honer; Julie A Schneider; David A Bennett; Martha Clare Morris
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Authors:  Nicolas Farina; David Llewellyn; Mokhtar Gad El Kareem Nasr Isaac; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2017-04-18

Review 6.  All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.

Authors:  Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

Review 7.  Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Authors:  Nicolas Farina; Mokhtar Gad El Kareem Nasr Isaac; Annalie R Clark; Jennifer Rusted; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 8.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

9.  Modulation of Brain Glutathione Reductase and Peroxiredoxin 2 by α-Tocopheryl Phosphate.

Authors:  Mariana Figueiroa Uchoa; Luiz Felipe de Souza; Danubia Bonfanti Dos Santos; Tanara Vieira Peres; Danielle Ferraz Mello; Rodrigo Bainy Leal; Marcelo Farina; Alcir Luiz Dafre
Journal:  Cell Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.046

10.  Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.

Authors:  Jason Lockrow; Annamalai Prakasam; Peng Huang; Heather Bimonte-Nelson; Kumar Sambamurti; Ann-Charlotte Granholm
Journal:  Exp Neurol       Date:  2008-12-10       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.